In recent trading session, Petros Pharmaceuticals Inc (NASDAQ:PTPI) saw 1.66 million shares changing hands at last check today with its beta currently measuring 1.98. Company’s recent per share price level of $0.32 trading at -$0.03 or -8.29% at last check today assigns it a market valuation of $3.23M. That most recent trading price of PTPI’s stock is at a discount of -609.38% from its 52-week high price of $2.27 and is indicating a premium of 31.25% from its 52-week low price of $0.22. Taking a look at company’s average trading volume for last 10-days demonstrates a volume of 8.24 million shares which gives us an average trading volume of 1.48 million if we extend that period to 3-months.
Petros Pharmaceuticals Inc (NASDAQ:PTPI) trade information
Upright in the red during last session for losing -8.29%, in the last five days PTPI remained trading in the red while hitting it’s week-highest on Tuesday, 12/17/24 when the stock touched $0.32 price level, adding 45.36% to its value on the day. Petros Pharmaceuticals Inc’s shares saw a change of -77.16% in year-to-date performance and have moved -8.05% in past 5-day. Petros Pharmaceuticals Inc (NASDAQ:PTPI) showed a performance of 28.24% in past 30-days. Number of shares sold short was 0.2 million shares which calculate 0.72 days to cover the short interests.
Petros Pharmaceuticals Inc (NASDAQ:PTPI)’s Major holders
Insiders are in possession of 8.10% of company’s total shares while institution are holding 2.29 percent of that, with stock having share float percentage of 2.49%. Investors also watch the number of corporate investors in a company very closely, which is 2.29% institutions for Petros Pharmaceuticals Inc that are currently holding shares of the company.
On the other hand, Fidelity Extended Market Index Fund and Vanguard Extended Market Index Fund are the top two Mutual Funds which own company’s shares. As of Oct 31, 2024, the former fund manager was holding 35.02 shares of worth $11701.0 or 0.35% of the total outstanding shares. The later fund manager was in possession of 31.81 shares on Sep 30, 2024, making its stake of worth around $10628.0 in the company or a holder of 0.32% of company’s stock.
